Grantee Research Project Results
Associated Project Details for RFA: Organotypic Culture Models for Predictive Toxicology Center (2013)R835736 | Vanderbilt - Pittsburgh Resource for Organotypic Models for Predictive Toxicology | Centers | December 1, 2014 through November 30, 2018 (Extended to November 30, 2019) |
R835736C001 | Mammosphere Bioreactor For Life-Stage Specific Toxicology | Centers | December 1, 2014 through November 30, 2018 (Extended to November 30, 2019) |
R835736C002 | Organotypic Culture Model to Analyze DevelopmentalLimbMalformationsResulting from Toxicant/Teratogen Exposure | Centers | December 1, 2014 through November 30, 2018 (Extended to November 30, 2019) |
R835736C003 | Validating a fetal membrane on a chip model for characterizing reproductive toxicant exposure risks | Centers | December 1, 2014 through November 30, 2018 (Extended to November 30, 2019) |
R835736C004 | Organotypic Liver Model for Predictive Human Toxicology and Metabolism | Centers | December 1, 2014 through November 30, 2018 (Extended to November 30, 2019) |
R835736C005 | Systems Engineering & Analysis for Organotypic Culture Models | Centers | December 1, 2014 through November 30, 2018 (Extended to November 30, 2019) |
R835737 | Human Models for Analysis of Pathways (H MAPs) Center | Centers | December 1, 2014 through November 30, 2018 (Extended to November 30, 2019) |
R835737C001 | Liver MAPs | Centers | December 1, 2014 through November 30, 2018 (Extended to November 30, 2019) |
R835737C002 | Brain MAPs | Centers | December 1, 2014 through November 30, 2018 (Extended to November 30, 2019) |
R835737C003 | Cancer MAPs: A 3D Organotypic Microfluidic Culture System to Identify Chemicals that Impact Progression and Development of Breast Cancer | Centers | December 1, 2014 through November 30, 2018 (Extended to November 30, 2019) |
R835737C004 | Vascular MAPs: Vascular and Neurovascular Tissue Models | Centers | December 1, 2014 through November 30, 2018 (Extended to November 30, 2019) |
R835737C005 | Pathway Analysis Core | Centers | December 1, 2014 through November 30, 2018 (Extended to November 30, 2019) |
R835738 | Predictive Toxicology Center for Organotypic Cultures and Assessment ofAOPs for Engineered Nanomaterials | Centers | December 1, 2014 through November 30, 2019 (Extended to November 30, 2020) |
R835738C001 | Airway Epithelium Organotypic Culture as a Platform forAdverseOutcomesPathway Assessment of Engineered Nanomaterials | Centers | December 1, 2014 through November 30, 2018 (Extended to November 30, 2020) |
R835738C002 | Organotypic Model of Human Kidney as a Platform for Adverse Outcomes Pathway Assessment of Engineered Nanomaterials | Centers | December 1, 2014 through November 30, 2018 (Extended to November 30, 2019) |
R835738C003 | Organotypic Models of Mammalian Liver as a Platform for Adverse Outcomes Pathway Assessment of Engineered Nanomaterials | Centers | December 1, 2014 through November 30, 2018 (Extended to November 30, 2019) |
R835738C004 | Organotypic Model of Testis as a Platform for Adverse Outcomes Pathway Assessment of Engineered Nanomaterials | Centers | December 1, 2014 through November 30, 2018 (Extended to November 30, 2019) |
R835738C005 | Integrating Liver, Kidney and Testis Nanomaterial Toxicity using the Adverse Outcome Pathway Approach | Centers | December 1, 2014 through November 30, 2018 (Extended to November 30, 2019) |
R835802 | Cardiotoxicity Adverse Outcome Pathway: Organotypic Culture Model and in vitro-to-in vivo Extrapolation for High-throughput Hazard, Dose-response and Variability Assessments | Centers | June 1, 2015 through May 31, 2019 (Extended to May 31, 2022) |
R835802C001 | High-throughput Hazard,Dose-responseandPopulationVariabilityAssessmentofCardiotoxicity in aHumanInducedPluripotentStem Cell(iPSC)-derivedinvitro Culture Model | Centers | June 1, 2015 through May 31, 2019 (Extended to May 31, 2021) |
R835802C002 | Linking in vitro-to-in vivoToxicity Testing Using Genetically-matchedOrganoids and Mice from a Novel Genetic Reference Population | Centers | June 1, 2015 through May 31, 2019 (Extended to May 31, 2020) |
R835802C003 | A Pipeline for in vitro-to-in vivo Extrapolation, Population Modeling, & Prioritization | Centers | June 1, 2015 through May 31, 2019 (Extended to May 31, 2020) |
The perspectives, information and conclusions conveyed in research project abstracts, progress reports, final reports, journal abstracts and journal publications convey the viewpoints of the principal investigator and may not represent the views and policies of ORD and EPA. Conclusions drawn by the principal investigators have not been reviewed by the Agency.